Inspiremd Announces Updated Timing For Third Quarter 2026 Financial Results
The revised timing will allow management to provide investors with a more comprehensive update on the Company's recent developments and business activities in conjunction with its third quarter financial results.
Parties interested in participating by phone should register using this online form. After registering for the webcast, dial-in details will be provided in an auto-generated e-mail containing a link to the conference phone number along with a personal pin. A live audio webcast and an archive of the recording will be available here and through the Investors page of InspireMD's corporate website at . Interested participants are encouraged to register more than 15 minutes before the start of the call.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNetTM mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit .
Investor Contact:
Jeff Warren
LifeSci Advisors
...
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment